1 |
Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.
DOI
ScienceOn
|
2 |
Blich M, Zeidan-Shwiri T, Petcherski S, Osherov A, Hammerman H. Incidence, predictors and outcome of drug-eluting stent thrombosis in real- world practice. J Invasive Cardiol 2010;22:461-4.
|
3 |
Lee AY. Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants. Hematology Am Soc Hematol Educ Program 2010;2010:144-9.
DOI
|
4 |
Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 2009;27:4839-47.
DOI
ScienceOn
|
5 |
De Cicco M. The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol 2004;50:187-96.
DOI
ScienceOn
|
6 |
Nakagawa T, Yasuno M, Tanahashi H, et al. A case of acute myocardial infarction: intracoronary thrombosis in two major coronary arteries due to hormone therapy. Angiology 1994;45:333-8.
DOI
ScienceOn
|
7 |
Canale ML, Camerini A, Stroppa S, et al. A case of acute myocardial infarction during 5-fluorouracil infusion. J Cardiovasc Med (Hagerstown) 2006;7:835-7.
DOI
ScienceOn
|
8 |
Wijesinghe N, Thompson PI, McAlister H. Acute coronary syndrome induced by capecitabine therapy. Heart Lung Circ 2006;15:337-9.
DOI
ScienceOn
|
9 |
Kalapura T, Krishnamurthy M, Reddy CV. Acute myocardial infarction following gemcitabine therapy: a case report. Angiology 1999;50:1021-5.
DOI
ScienceOn
|
10 |
Gemici G, Cinçin A, Degertekin M, Oktay A. Paclitaxel-induced ST-segment elevations. Clin Cardiol 2009;32:E94-6.
DOI
|
11 |
Lee SP, Suh JW, Park KW, et al. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: a multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease. Trials 2010;11:87.
DOI
|
12 |
Gurbel PA, Bliden KP, Butler K, et al. Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the respond study. Circulation 2010;121:1188-99.
DOI
ScienceOn
|
13 |
Montalescot G, Wiviott SD, Braunwald E, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009;373:723-31.
DOI
ScienceOn
|